More than 7,300 delegates at the American Diabetes Association's 72nd Scientific Sessions, were on hand to hear the first public presentation of the ORIGIN Trial results, as presented by the ORIGIN Trial Operations Committee on June 11, 2012 in Philadelphia.
Sanofi’s insulin glargine delays progression from pre-diabetes to T2DM Posted June 15, 2012 by News Medical ADA: Omega-3 fatty acids don't cut CV death Posted June 15, 2012 by The Clinical Advisor Insulin glargine gets resounding safety vote Posted June 13, 2012 by Canadian Medical Association Omega-3 supplementation fails to prevent CV events in diabetes Posted June 13, 2012 by Canadian Medical Association Omega-3 fish oil supplements questioned Posted June 13, 2012 by CBC News Long-term insulin use does not increase risk of heart disease in people with diabetes Posted June 13, 2012 by News Medical Leading Insulin Doesn't Heighten Cancer Risk, Studies Find Posted June 12, 2012 by The Wall Street Journal ADA: No Cancer Risk with Lantus Posted June 12, 2012 by MedPage Today Fish oil components may not benefit everyone's heart Posted June 12, 2012 by Science News Heart, cancer risk no higher with long-term insulin use Posted June 12, 2012 by CBC News ADA cancer-risk data clears Sanofi's Lantus Posted June 12, 2012 by FiercePharma Sanofi reports results of ORIGIN trail Posted June 12, 2012 by MENAFN McMaster study debunks belief insulin puts people with diabetes at risk of heart disease Posted June 12, 2012 by McMaster Daily News The ORIGIN Trial: 8 questions, 8 answers Posted June 11, 2012 by Diabetes-symposium.org Sanofi’s Lantus Had No Increased Cancer Risk in Studies Posted June 11, 2012 by Bloomberg Fish Oil Or Snake Oil? Study Questions Omega-3 Benefits Posted June 11, 2012 by Forbes Three studies back Sanofi's Lantus safety Posted June 11, 2012 by Reuters Sanofi Announces Results Of Origin Trial Posted June 11, 2012 by RTTNews Sanofi's Lantus Doesn't Reduce Heart-Attack Risk in Diabetes Study Posted June 11, 2012 by Fox Business Fish Oil Won't Save Diabetics' Hearts, Research Suggests Posted June 11, 2012 by US News ORIGIN: Insulin glargine and n-3 fatty acids do not reduce CVD events in diabetics Posted June 11, 2012 by theheart.org ADA: Omega-3 Fatty Acids Don’t Cut Cardiovascular Death Posted June 11, 2012 by DoctorsLounge